Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Desperate Muscle Cells Produce Nerve Regenerating MicroRNA

By LabMedica International staff writers
Posted on 21 Dec 2009
Neuroscientists are investigating the possible therapeutic applications of a class of microRNA (miRNA) produced by damaged muscle cells in patients with amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease).

ALS is a neurodegenerative disease with no known cause characterized by loss of motor neurons, denervation of target muscles, muscle atrophy, and paralysis. More...
As the disease progresses and muscle tissues begin to degenerate due to lack of nerve stimulation, muscle cells produce various molecules aimed at stimulating regeneration of nerves.

Investigators at the University of Texas Southwestern Medical Center (Dallas, USA) studied one of these molecules, the microRNA miR-206. They reported in the December 11, 2009 issue of the journal Science that the skeletal muscle specific miRNA-206 was a key regulator of nerve regeneration signaling, and that it was dramatically induced in a mouse model of ALS. Mice that were genetically deficient in miR-206 formed normal neuromuscular synapses during development, but deficiency of miR-206 in the ALS mouse model accelerated disease progression. MiR-206 was required for efficient regeneration of neuromuscular synapses after acute nerve injury, which, thought the investigators, probably accounted for its salutary effects in ALS.

"MiR-206 seems to sense nerve injury and promote regeneration," said senior author Dr. Eric Olson, professor of molecular biology at the University of Texas Southwestern Medical Center. "While miR-206 initially prompts nearby surviving nerves to send new branches to the muscles, it only delays the inevitable. Our findings correlate with the observation in ALS patients that the disease is nearly asymptomatic until a large fraction of motor neurons has died, at which point the few remaining ones cannot compensate sufficiently. These results provide a new perspective on the mechanisms of ALS. Because miR-206 only exists in skeletal muscle, a drug based on it might not affect other tissues. That limits its risk of side effects and is a key part of its appeal as a potential therapy."

Related Links:
University of Texas Southwestern Medical Center



New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Alcohol Testing Device
Dräger Alcotest 7000
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.